Danske Bank’s Altimmune ALT Stock Holding History

Danske Bank’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-36,370	Closed	-$370K	–	1150
2024 Q1	$370K	Buy	+36,370	New	+$370K	﹤0.01%	899

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Danske Bank's ALT Position: Q2 2024 in Review

Danske Bank sold out of Altimmune (ALT) in Q2 2024, closing a stake of 36,370 shares — an estimated $370K sold.

Danske Bank first reported a position in ALT in Q1 2024 and held it in 1 quarter. The position peaked at $370K in Q1 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q2 2024.

Danske Bank reported no remaining Altimmune position as of Q2 2024 after selling out during the quarter.
Danske Bank sold 36,370 Altimmune shares in Q2 2024, an estimated $370K.
Danske Bank first reported a position in Altimmune in Q1 2024 and held it in 1 quarter.
Danske Bank's Altimmune position peaked at $370K in Q1 2024.
173 funds tracked by Wall St. Rank held Altimmune as of Q2 2024.

Based on Danske Bank's 13F filing for Q2 2024, filed 18 Mar 2026.